Wednesday, 14 December 2016

Sensex Finishes Down 95 Points Ahead of US Fed Decision

The Indian share markets witnessed some selling pressure during the afternoon session and finished the day below the dotted line ahead of US Fed rate decision to be announced today.

At the closing bell, the BSE Sensex closed lower by 95 points, whereas the NSE Nifty finished down by 39 points.

The S&P BSE Midcap & the S&P BSE Smallcap finished down by 0.8% and 0.9% respectively.
Barring IT sector and realty stocks, all sectoral indices ended the day in red. Metal stocks and PSU stocks led the losses.

Meanwhile, here is a list of BSE gainers today.

Moving on to the news from stocks in Pharma sector.

The pharma industry as whole is undergoing regulatory crackdowns. Considering the pharma’s regulatory distresses, are Indian pharma companies now adapting to the scrutiny by the USFDA? (Subscription Required. Our pharma sector analyst, Bhavita Nagrani, is of the opinion that Lupin was able to insulate its growth despite rising pressures in the sector. She has recently shared a detailed view on the company and valuations in the recommendation report of The India Letter.

Lupin share price ended the day down by 0.4%.

As we wrote this share market news, oil prices were trading at US$ 52.37.

At last, if you have any query, use Equitymaster's online stock screener to scan stocks listed in BSE and NSE stock exchanges in India using various key metrics like share price, market cap, P/E ratio, dividend yield and more.


Read the complete Indian stock market update. For terms of use, go here.

No comments:

Post a Comment